Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Novo Nordisk A/S (NYSE:NVO) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer said that he ...

Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...

Novo Banco spun out of the collapsed Banco Espirito Santo (BES) in 2014 after a state bailout. US investor Lone Star, which ...

Novo Banco’s majority shareholder, Nani Holdings, a unit of private equity firm Lone Star Funds, is selling its 75% stake, in ...

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Amycretin, the Danish drugmaker’s next-generation obesity drug, has a dual-mode action. Like its popular weight-loss drug ...

LONDON, June 12, 2025 /PRNewswire/ — Fortune announced today the inaugural list of Europe’s Most Innovative Companies, recognizing the top 300 companies who are reinventing the future in unexpected ...

Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq ...

As part of the license agreement with Novo, Deep Apple will be eligible to receive up to $812 million in payments, as well as ...

Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for ...

Gefion has already been used by multiple customers to advance healthcare and drug discovery.